HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandra Bortoluzzi Selected Research

Alessandra Bortoluzzi Research Topics

Disease

11Rheumatoid Arthritis
10/2021 - 07/2010
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2016
4Arthritis (Polyarthritis)
12/2021 - 01/2018
4Proteinuria
11/2021 - 01/2018
3Infections
02/2022 - 11/2018
3Autoimmune Diseases (Autoimmune Disease)
07/2021 - 01/2019
3Inflammation (Inflammations)
01/2021 - 03/2017
3Rheumatic Diseases (Rheumatism)
01/2021 - 11/2018
3Psoriatic Arthritis
01/2021 - 03/2017
3Serositis
09/2020 - 01/2016
3Necrosis
11/2018 - 06/2010
2Adult-Onset Still's Disease
01/2020 - 12/2019
1Hypertension (High Blood Pressure)
11/2021
1Lupus Nephritis
11/2021
1COVID-19
07/2021
1Acquired Immunodeficiency Syndrome (AIDS)
02/2021
1Synovitis
01/2021
1Exanthema (Rash)
01/2021
1Hemolytic Anemia
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
02/2020
1Kidney Diseases (Kidney Disease)
02/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2020
1Stillbirth
01/2020
1Spontaneous Abortion (Miscarriage)
01/2020
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2019
1Congenital heart block
01/2019
1Raynaud Disease (Raynaud's Disease)
01/2019
1Heart Failure
01/2019
1Neonatal Systemic lupus erythematosus
01/2019
1Bacterial Infections (Bacterial Infection)
01/2019
1Atherosclerosis
01/2018
1Ankylosing Spondylitis
03/2017
1Systemic Scleroderma (Systemic Sclerosis)
06/2010

Drug/Important Bio-Agent (IBA)

8Biological ProductsIBA
10/2021 - 08/2014
8Antirheumatic Agents (DMARD)IBA
10/2021 - 07/2010
4belimumabIBA
11/2021 - 01/2018
4Etanercept (Enbrel)FDA Link
06/2020 - 03/2018
3AntibodiesIBA
12/2021 - 01/2019
3GlucocorticoidsIBA
07/2021 - 11/2018
3Pharmaceutical PreparationsIBA
02/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
3Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 08/2014
3CytokinesIBA
01/2019 - 01/2018
2LigandsIBA
02/2022 - 06/2010
2AutoantibodiesIBA
07/2021 - 01/2019
2Antinuclear AntibodiesIBA
01/2021 - 01/2019
2Interleukin-1 (Interleukin 1)IBA
01/2020 - 12/2019
2Prednisone (Sone)FDA LinkGeneric
01/2020 - 01/2018
2Abatacept (Orencia)FDA Link
01/2019 - 01/2019
2Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2017 - 01/2016
2OsteoprotegerinIBA
07/2010 - 06/2010
1KIR2DL2 ReceptorsIBA
02/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1CreatinineIBA
11/2021
1Rituximab (Mabthera)FDA Link
07/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2021
1C-Reactive ProteinIBA
07/2021
1Antiphospholipid AntibodiesIBA
09/2020
1Vitamin DFDA LinkGeneric
02/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2020
1Prostaglandins AIBA
01/2020
1Leflunomide (Arava)FDA LinkGeneric
01/2019
1Purinergic P2X7 ReceptorsIBA
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Tumor Necrosis Factor InhibitorsIBA
11/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2018
1tocilizumab (atlizumab)FDA Link
03/2018
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018
1Adenosine (Adenocard)FDA LinkGeneric
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1TNF-Related Apoptosis-Inducing LigandIBA
07/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010

Therapy/Procedure

3Therapeutics
11/2021 - 08/2014
1Biological Therapy
07/2021
1Immunomodulation
07/2021
1Precision Medicine
02/2021
1Aftercare (After-Treatment)
08/2014